| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.95e-12 | 188 | 58 | 11 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | FBLN1 SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 ITLN1 SLIT1 DLK2 SCUBE3 LTBP1 CDH6 FBN3 SVEP1 NOTCH4 | 2.40e-10 | 749 | 58 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | Notch binding | 1.07e-06 | 27 | 58 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | structural molecule activity | FBLN1 RELN FBN1 FBN2 HMCN1 TNC KRTAP29-1 LAMB1 LAMB2 LTBP1 FBN3 BGN | 7.74e-06 | 891 | 58 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | integrin binding | 1.15e-05 | 175 | 58 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 2.48e-05 | 3 | 58 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 6.01e-05 | 73 | 58 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 6.47e-05 | 27 | 58 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | microfibril binding | 1.23e-04 | 6 | 58 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 5.37e-04 | 12 | 58 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 7.38e-04 | 14 | 58 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 8.50e-04 | 15 | 58 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 9.69e-04 | 16 | 58 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 9.99e-04 | 547 | 58 | 7 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 1.08e-03 | 554 | 58 | 7 | GO:0030546 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.69e-03 | 599 | 58 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.94e-03 | 85 | 58 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.94e-03 | 85 | 58 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 1.98e-03 | 616 | 58 | 7 | GO:0030545 | |
| GeneOntologyMolecularFunction | fibronectin binding | 5.45e-03 | 38 | 58 | 2 | GO:0001968 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 8.42e-08 | 4 | 58 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.17e-06 | 8 | 58 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | response to wounding | FBLN1 SCUBE1 TNC DGKK LAMB2 PRKCD PLAUR PRKCQ WNT4 SVEP1 NOTCH4 | 1.89e-06 | 659 | 58 | 11 | GO:0009611 |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.43e-06 | 11 | 58 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 4.56e-06 | 12 | 58 | 3 | GO:0070831 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 5.92e-06 | 13 | 58 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 5.92e-06 | 13 | 58 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 6.40e-06 | 43 | 58 | 4 | GO:0071711 | |
| GeneOntologyBiologicalProcess | blood coagulation | 8.11e-06 | 260 | 58 | 7 | GO:0007596 | |
| GeneOntologyBiologicalProcess | wound healing | 8.91e-06 | 493 | 58 | 9 | GO:0042060 | |
| GeneOntologyBiologicalProcess | coagulation | 9.40e-06 | 266 | 58 | 7 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 9.87e-06 | 268 | 58 | 7 | GO:0007599 | |
| GeneOntologyBiologicalProcess | renal system development | 1.18e-05 | 386 | 58 | 8 | GO:0072001 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 1.38e-05 | 109 | 58 | 5 | GO:0034446 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.47e-05 | 285 | 58 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.50e-05 | 286 | 58 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 1.61e-05 | 531 | 58 | 9 | GO:0042692 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 3.13e-05 | 442 | 58 | 8 | GO:0050878 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HMCN1 WNT7B LAMB1 PRKCD PLAUR PRKCQ WNT4 TEK CDH6 SVEP1 MEGF10 NOTCH4 | 3.70e-05 | 1077 | 58 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | DGCR2 NTN4 FBN2 LRIG1 DLL4 TNC WNT7B SLIT1 LAMB1 LAMB2 SNAI1 WNT4 TEK | 3.99e-05 | 1269 | 58 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | epithelium development | NTN4 SCUBE1 HDAC5 DLL4 TNC IL20 WNT7B LAMB2 PLAUR SNAI1 WNT4 TEK KANK2 NOTCH4 | 4.21e-05 | 1469 | 58 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | FBLN1 TNC LAMB1 LAMB2 PRKCD PLAUR PRKCQ WNT4 TEK MEGF10 NOTCH4 | 4.66e-05 | 927 | 58 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 5.18e-05 | 236 | 58 | 6 | GO:0061138 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 5.34e-05 | 619 | 58 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 6.58e-05 | 28 | 58 | 3 | GO:0072207 | |
| GeneOntologyBiologicalProcess | axon development | 7.07e-05 | 642 | 58 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cell junction organization | RELN TNC WNT7B SLIT1 CNTNAP2 LAMB2 SNAI1 WNT4 TEK CDH6 SVEP1 | 7.29e-05 | 974 | 58 | 11 | GO:0034330 |
| GeneOntologyBiologicalProcess | Tie signaling pathway | 7.73e-05 | 5 | 58 | 2 | GO:0048014 | |
| GeneOntologyBiologicalProcess | kidney development | 8.00e-05 | 372 | 58 | 7 | GO:0001822 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 8.48e-05 | 258 | 58 | 6 | GO:0001763 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoblast differentiation | 1.10e-04 | 88 | 58 | 4 | GO:0045669 | |
| GeneOntologyBiologicalProcess | muscle structure development | HDAC5 DLL4 WNT7B CNTNAP2 LAMB1 LAMB2 WNT4 ADAM12 MEGF10 NOTCH4 | 1.25e-04 | 858 | 58 | 10 | GO:0061061 |
| GeneOntologyBiologicalProcess | response to hormone | KMT2D FBN1 HDAC5 TNC WNT7B INSRR CNTNAP2 PRKCD PRKCQ TEK KANK2 | 1.33e-04 | 1042 | 58 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.46e-04 | 410 | 58 | 7 | GO:0031589 | |
| GeneOntologyBiologicalProcess | circulatory system development | SCUBE1 STAB2 FBN1 HDAC5 DLL4 WNT7B LTBP1 SNAI1 WNT4 TEK ADAM12 SVEP1 NOTCH4 | 1.47e-04 | 1442 | 58 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | metanephros development | 1.48e-04 | 95 | 58 | 4 | GO:0001656 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.75e-04 | 566 | 58 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 2.00e-04 | 302 | 58 | 6 | GO:0001649 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | FBLN1 FBN1 HDAC5 DLL4 WNT7B SLIT1 CNTNAP2 PRKCD PLAUR WNT4 TEK LIN28A SVEP1 | 2.00e-04 | 1488 | 58 | 13 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 2.04e-04 | 192 | 58 | 5 | GO:0045667 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 2.05e-04 | 579 | 58 | 8 | GO:0045785 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 2.28e-04 | 750 | 58 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 2.35e-04 | 198 | 58 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 2.41e-04 | 199 | 58 | 5 | GO:0051147 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | RELN FBN2 IL20 WNT7B SCUBE3 LAMB1 LAMB2 SNAI1 WNT4 LIN28A NOTCH4 | 2.92e-04 | 1141 | 58 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 3.08e-04 | 210 | 58 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 3.13e-04 | 47 | 58 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | branching involved in blood vessel morphogenesis | 3.13e-04 | 47 | 58 | 3 | GO:0001569 | |
| GeneOntologyBiologicalProcess | negative regulation of Notch signaling pathway | 3.34e-04 | 48 | 58 | 3 | GO:0045746 | |
| GeneOntologyBiologicalProcess | vasculature development | 3.35e-04 | 969 | 58 | 10 | GO:0001944 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FBN1 FBN2 INSRR SCUBE3 PRKCD PLAUR LTBP1 PRKCQ WNT4 TEK SVEP1 | 4.07e-04 | 1186 | 58 | 11 | GO:0007167 |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 4.11e-04 | 124 | 58 | 4 | GO:0034109 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | FBLN1 KMT2D HDAC5 DLL4 TNC WNT7B LAMB1 PRKCQ TEK LIN28A MEGF10 | 4.19e-04 | 1190 | 58 | 11 | GO:0008284 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 4.21e-04 | 11 | 58 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NTN4 RELN WNT7B SLIT1 CNTNAP2 LAMB1 LAMB2 PRKCQ CDH6 NOTCH4 BRWD1 | 4.31e-04 | 1194 | 58 | 11 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 4.47e-04 | 53 | 58 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | positive regulation of protein import into nucleus | 4.73e-04 | 54 | 58 | 3 | GO:0042307 | |
| GeneOntologyBiologicalProcess | cartilage morphogenesis | 5.04e-04 | 12 | 58 | 2 | GO:0060536 | |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 5.54e-04 | 57 | 58 | 3 | GO:0061383 | |
| GeneOntologyBiologicalProcess | inflammatory response | 5.97e-04 | 1043 | 58 | 10 | GO:0006954 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 6.13e-04 | 59 | 58 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 6.92e-04 | 14 | 58 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 7.97e-04 | 15 | 58 | 2 | GO:0043652 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 8.51e-04 | 66 | 58 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 9.25e-04 | 727 | 58 | 8 | GO:0032870 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 9.29e-04 | 68 | 58 | 3 | GO:0007528 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 9.69e-04 | 69 | 58 | 3 | GO:0006911 | |
| GeneOntologyBiologicalProcess | ossification | 9.69e-04 | 562 | 58 | 7 | GO:0001503 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.02e-03 | 158 | 58 | 4 | GO:0030168 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.03e-03 | 412 | 58 | 6 | GO:0090287 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 1.04e-03 | 1327 | 58 | 11 | GO:0040012 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.04e-03 | 569 | 58 | 7 | GO:0034329 | |
| GeneOntologyBiologicalProcess | blood vessel development | 1.07e-03 | 929 | 58 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 1.10e-03 | 72 | 58 | 3 | GO:0022029 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.11e-03 | 748 | 58 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 1.12e-03 | 162 | 58 | 4 | GO:0072073 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.15e-03 | 421 | 58 | 6 | GO:0060562 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 1.23e-03 | 75 | 58 | 3 | GO:0021885 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 1.38e-03 | 78 | 58 | 3 | GO:0099024 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleocytoplasmic transport | 1.43e-03 | 79 | 58 | 3 | GO:0046824 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 1.45e-03 | 780 | 58 | 8 | GO:0042327 | |
| GeneOntologyBiologicalProcess | nephron development | 1.46e-03 | 174 | 58 | 4 | GO:0072006 | |
| GeneOntologyBiologicalProcess | aorta development | 1.49e-03 | 80 | 58 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | regulation of protein import into nucleus | 1.54e-03 | 81 | 58 | 3 | GO:0042306 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.73e-03 | 802 | 58 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 1.73e-03 | 22 | 58 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | spinal cord patterning | 1.73e-03 | 22 | 58 | 2 | GO:0021511 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.75e-03 | 309 | 58 | 5 | GO:1901888 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 1.86e-03 | 1211 | 58 | 10 | GO:0030334 | |
| GeneOntologyBiologicalProcess | membrane invagination | 1.89e-03 | 87 | 58 | 3 | GO:0010324 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.89e-03 | 23 | 58 | 2 | GO:2001044 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 1.89e-03 | 23 | 58 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 1.89e-03 | 23 | 58 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.94e-03 | 817 | 58 | 8 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.97e-03 | 819 | 58 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.08e-03 | 826 | 58 | 8 | GO:0048858 | |
| GeneOntologyCellularComponent | extracellular matrix | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 LRIG1 OTOGL TNC ITLN1 LAMB1 LAMB2 LTBP1 WNT4 FBN3 SVEP1 BGN | 1.35e-12 | 656 | 58 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 LRIG1 OTOGL TNC ITLN1 LAMB1 LAMB2 LTBP1 WNT4 FBN3 SVEP1 BGN | 1.41e-12 | 658 | 58 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 TNC ITLN1 LAMB1 LAMB2 LTBP1 BGN | 1.92e-08 | 530 | 58 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 3.74e-08 | 13 | 58 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 4.56e-08 | 122 | 58 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.24e-07 | 17 | 58 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin complex | 2.40e-06 | 10 | 58 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.57e-06 | 332 | 58 | 8 | GO:0005788 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.17e-05 | 59 | 58 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | cell surface | SCUBE1 STAB2 TREML4 WNT7B CNTNAP2 SCUBE3 PLAUR WNT4 TEK CD163 NOTCH4 BGN | 4.40e-05 | 1111 | 58 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.84e-03 | 212 | 58 | 4 | GO:0030666 | |
| GeneOntologyCellularComponent | Golgi lumen | 3.46e-03 | 109 | 58 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 3.56e-03 | 32 | 58 | 2 | GO:0005721 | |
| HumanPheno | Abnormality of the pulmonary artery | 4.23e-05 | 274 | 26 | 8 | HP:0004414 | |
| HumanPheno | Abnormal pulmonary artery morphology | 4.24e-05 | 133 | 26 | 6 | HP:0030966 | |
| Domain | EGF_1 | NTN4 FBLN1 RELN SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LAMB1 LAMB2 LTBP1 TEK ADAM12 FBN3 SVEP1 MEGF10 NOTCH4 | 1.66e-28 | 255 | 57 | 23 | PS00022 |
| Domain | EGF-like_CS | NTN4 FBLN1 RELN SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LAMB1 LAMB2 LTBP1 TEK ADAM12 FBN3 SVEP1 MEGF10 NOTCH4 | 2.87e-28 | 261 | 57 | 23 | IPR013032 |
| Domain | EGF-like_dom | FBLN1 RELN SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LAMB1 LAMB2 LTBP1 TEK ADAM12 FBN3 SVEP1 MEGF10 NOTCH4 | 5.04e-27 | 249 | 57 | 22 | IPR000742 |
| Domain | EGF_2 | FBLN1 RELN SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LAMB1 LAMB2 LTBP1 TEK ADAM12 FBN3 SVEP1 MEGF10 NOTCH4 | 2.05e-26 | 265 | 57 | 22 | PS01186 |
| Domain | Growth_fac_rcpt_ | NTN4 FBLN1 SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 INSRR SCUBE3 LAMB1 LAMB2 LTBP1 TEK FBN3 SVEP1 NOTCH4 | 5.14e-26 | 156 | 57 | 19 | IPR009030 |
| Domain | EGF | FBLN1 RELN SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LAMB1 LAMB2 LTBP1 TEK FBN3 SVEP1 MEGF10 NOTCH4 | 7.19e-26 | 235 | 57 | 21 | SM00181 |
| Domain | EGF_3 | FBLN1 RELN SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LTBP1 TEK ADAM12 FBN3 SVEP1 MEGF10 NOTCH4 | 3.50e-24 | 235 | 57 | 20 | PS50026 |
| Domain | EGF_CA | FBLN1 SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 SLIT1 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 7.27e-19 | 122 | 57 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | FBLN1 SCUBE1 STAB2 FBN1 FBN2 HMCN1 DLL4 SLIT1 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 9.20e-19 | 124 | 57 | 14 | IPR001881 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBLN1 SCUBE1 FBN1 FBN2 HMCN1 DLL4 SLIT1 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 5.90e-18 | 106 | 57 | 13 | IPR000152 |
| Domain | EGF_Ca-bd_CS | FBLN1 SCUBE1 FBN1 FBN2 HMCN1 SLIT1 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 1.11e-16 | 97 | 57 | 12 | IPR018097 |
| Domain | EGF_CA | FBLN1 SCUBE1 FBN1 FBN2 HMCN1 SLIT1 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 1.44e-16 | 99 | 57 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | FBLN1 SCUBE1 FBN1 FBN2 HMCN1 DLL4 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 1.63e-16 | 100 | 57 | 12 | PS00010 |
| Domain | EGF | STAB2 HMCN1 DLL4 TNC SLIT1 CNTNAP2 DLK2 SCUBE3 LTBP1 FBN3 SVEP1 NOTCH4 | 2.85e-15 | 126 | 57 | 12 | PF00008 |
| Domain | cEGF | 6.75e-15 | 26 | 57 | 8 | IPR026823 | |
| Domain | cEGF | 6.75e-15 | 26 | 57 | 8 | PF12662 | |
| Domain | EGF_CA | 9.05e-14 | 86 | 57 | 10 | PF07645 | |
| Domain | EGF_extracell | 1.55e-13 | 60 | 57 | 9 | IPR013111 | |
| Domain | EGF_2 | 1.55e-13 | 60 | 57 | 9 | PF07974 | |
| Domain | hEGF | 1.90e-12 | 28 | 57 | 7 | PF12661 | |
| Domain | TB | 2.71e-09 | 7 | 57 | 4 | PF00683 | |
| Domain | - | 5.41e-09 | 8 | 57 | 4 | 3.90.290.10 | |
| Domain | TB | 9.71e-09 | 9 | 57 | 4 | PS51364 | |
| Domain | TB_dom | 9.71e-09 | 9 | 57 | 4 | IPR017878 | |
| Domain | FBN | 2.70e-08 | 3 | 57 | 3 | IPR011398 | |
| Domain | EGF_Lam | 6.70e-08 | 35 | 57 | 5 | SM00180 | |
| Domain | Laminin_EGF | 1.03e-07 | 38 | 57 | 5 | IPR002049 | |
| Domain | EGF_LAM_2 | 2.01e-06 | 30 | 57 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 2.01e-06 | 30 | 57 | 4 | PS01248 | |
| Domain | Laminin_EGF | 3.80e-06 | 35 | 57 | 4 | PF00053 | |
| Domain | Znf_PHD-finger | 4.20e-06 | 79 | 57 | 5 | IPR019787 | |
| Domain | - | 4.37e-06 | 11 | 57 | 3 | 2.40.155.10 | |
| Domain | GFP-like | 4.37e-06 | 11 | 57 | 3 | IPR023413 | |
| Domain | Ephrin_rec_like | 4.37e-06 | 11 | 57 | 3 | PF07699 | |
| Domain | EGF_3 | 5.81e-06 | 12 | 57 | 3 | PF12947 | |
| Domain | EGF_dom | 5.81e-06 | 12 | 57 | 3 | IPR024731 | |
| Domain | Galactose-bd-like | 9.88e-06 | 94 | 57 | 5 | IPR008979 | |
| Domain | Laminin_N | 1.47e-05 | 16 | 57 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 1.47e-05 | 16 | 57 | 3 | PS51117 | |
| Domain | Laminin_N | 1.47e-05 | 16 | 57 | 3 | PF00055 | |
| Domain | LamNT | 1.47e-05 | 16 | 57 | 3 | SM00136 | |
| Domain | LAMININ_IVB | 2.74e-05 | 3 | 57 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 2.74e-05 | 3 | 57 | 2 | IPR013015 | |
| Domain | EPHD | 3.98e-05 | 22 | 57 | 3 | PS51805 | |
| Domain | Zinc_finger_PHD-type_CS | 4.59e-05 | 65 | 57 | 4 | IPR019786 | |
| Domain | Prot_kin_PKC_delta | 5.47e-05 | 4 | 57 | 2 | IPR014376 | |
| Domain | Ephrin_rec_like | 5.91e-05 | 25 | 57 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.91e-05 | 25 | 57 | 3 | IPR011641 | |
| Domain | PHD | 8.06e-05 | 75 | 57 | 4 | PF00628 | |
| Domain | FIBRINOGEN_C_1 | 1.26e-04 | 32 | 57 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.26e-04 | 32 | 57 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.26e-04 | 32 | 57 | 3 | PS51406 | |
| Domain | PHD | 1.57e-04 | 89 | 57 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.71e-04 | 91 | 57 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.02e-04 | 95 | 57 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.10e-04 | 96 | 57 | 4 | PS01359 | |
| Domain | Znf_RING | 4.63e-04 | 326 | 57 | 6 | IPR001841 | |
| Domain | LRRNT | 5.67e-04 | 53 | 57 | 3 | PF01462 | |
| Domain | C1_1 | 7.02e-04 | 57 | 57 | 3 | PF00130 | |
| Domain | IBR | 8.13e-04 | 14 | 57 | 2 | SM00647 | |
| Domain | IBR | 8.13e-04 | 14 | 57 | 2 | PF01485 | |
| Domain | IBR_dom | 9.37e-04 | 15 | 57 | 2 | IPR002867 | |
| Domain | ZF_DAG_PE_1 | 9.84e-04 | 64 | 57 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 9.84e-04 | 64 | 57 | 3 | PS50081 | |
| Domain | C1 | 1.03e-03 | 65 | 57 | 3 | SM00109 | |
| Domain | Znf_FYVE_PHD | 1.05e-03 | 147 | 57 | 4 | IPR011011 | |
| Domain | PE/DAG-bd | 1.08e-03 | 66 | 57 | 3 | IPR002219 | |
| Domain | Wnt | 1.51e-03 | 19 | 57 | 2 | IPR005817 | |
| Domain | Wnt_CS | 1.51e-03 | 19 | 57 | 2 | IPR018161 | |
| Domain | wnt | 1.51e-03 | 19 | 57 | 2 | PF00110 | |
| Domain | WNT1 | 1.51e-03 | 19 | 57 | 2 | SM00097 | |
| Domain | WNT1 | 1.51e-03 | 19 | 57 | 2 | PS00246 | |
| Domain | DAG/PE-bd | 1.85e-03 | 21 | 57 | 2 | IPR020454 | |
| Domain | ZF_RING_1 | 1.92e-03 | 291 | 57 | 5 | PS00518 | |
| Domain | ZF_RING_2 | 2.13e-03 | 298 | 57 | 5 | PS50089 | |
| Domain | RING | 2.35e-03 | 305 | 57 | 5 | SM00184 | |
| Domain | Bromodomain_CS | 2.84e-03 | 26 | 57 | 2 | IPR018359 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NTN4 FBLN1 SCUBE1 FBN1 FBN2 TNC SCUBE3 LAMB1 LAMB2 LTBP1 ADAM12 FBN3 BGN | 3.27e-11 | 300 | 51 | 13 | M610 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.02e-07 | 37 | 51 | 5 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.95e-07 | 44 | 51 | 5 | M26969 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.82e-06 | 25 | 51 | 4 | M39713 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.64e-06 | 258 | 51 | 8 | MM14572 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.84e-06 | 66 | 51 | 5 | M18 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.01e-06 | 118 | 51 | 6 | M39852 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.07e-05 | 140 | 51 | 6 | M587 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.69e-05 | 43 | 51 | 4 | M53 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.54e-05 | 97 | 51 | 5 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.09e-05 | 101 | 51 | 5 | M39448 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 4.15e-05 | 19 | 51 | 3 | M39370 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.97e-05 | 59 | 51 | 4 | M27218 | |
| Pathway | WP_WNT_SIGNALING | 6.81e-05 | 61 | 51 | 4 | MM15893 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 8.25e-05 | 124 | 51 | 5 | M27285 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 9.70e-05 | 25 | 51 | 3 | MM14511 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.23e-04 | 27 | 51 | 3 | M12123 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.23e-04 | 27 | 51 | 3 | M39545 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.61e-04 | 76 | 51 | 4 | M27219 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 2.05e-04 | 32 | 51 | 3 | M165 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.05e-04 | 32 | 51 | 3 | MM14854 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.25e-04 | 33 | 51 | 3 | M39503 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.37e-04 | 84 | 51 | 4 | M7098 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.81e-04 | 161 | 51 | 5 | M39770 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.54e-04 | 8 | 51 | 2 | M47850 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.72e-04 | 39 | 51 | 3 | MM14601 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 4.27e-04 | 98 | 51 | 4 | M39830 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 4.79e-04 | 101 | 51 | 4 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 4.79e-04 | 101 | 51 | 4 | M39387 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 5.32e-04 | 44 | 51 | 3 | M875 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 6.91e-04 | 11 | 51 | 2 | M27882 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 6.91e-04 | 11 | 51 | 2 | M158 | |
| Pathway | WP_BURN_WOUND_HEALING | 7.32e-04 | 113 | 51 | 4 | M42571 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.56e-04 | 114 | 51 | 4 | MM14571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 9.76e-04 | 13 | 51 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 9.76e-04 | 13 | 51 | 2 | M47534 | |
| Pathway | PID_NOTCH_PATHWAY | 1.26e-03 | 59 | 51 | 3 | M17 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.31e-03 | 15 | 51 | 2 | MM14965 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.49e-03 | 16 | 51 | 2 | M47424 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.69e-03 | 17 | 51 | 2 | M212 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.74e-03 | 66 | 51 | 3 | MM15925 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 2.11e-03 | 19 | 51 | 2 | M47836 | |
| Pathway | WP_AXON_GUIDANCE | 2.23e-03 | 72 | 51 | 3 | M48335 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.30e-03 | 154 | 51 | 4 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.91e-03 | 79 | 51 | 3 | M27643 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.09e-03 | 23 | 51 | 2 | MM14954 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 3.65e-03 | 25 | 51 | 2 | MM14940 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 3.65e-03 | 25 | 51 | 2 | M118 | |
| Pubmed | 1.12e-11 | 167 | 59 | 9 | 22159717 | ||
| Pubmed | 1.70e-11 | 175 | 59 | 9 | 28071719 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 7.84e-11 | 135 | 59 | 8 | 28675934 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.80e-10 | 248 | 59 | 9 | 24006456 | |
| Pubmed | 5.65e-09 | 146 | 59 | 7 | 27068509 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.77e-09 | 86 | 59 | 6 | 28327460 | |
| Pubmed | 7.82e-09 | 153 | 59 | 7 | 25037231 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 1.85e-08 | 4 | 59 | 3 | 25034023 | |
| Pubmed | 1.85e-08 | 4 | 59 | 3 | 12429738 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.05e-08 | 101 | 59 | 6 | 20551380 | |
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 34411563 | ||
| Pubmed | 4.79e-08 | 199 | 59 | 7 | 23382691 | ||
| Pubmed | 5.22e-08 | 118 | 59 | 6 | 21078624 | ||
| Pubmed | 8.34e-08 | 64 | 59 | 5 | 22261194 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 1.98e-07 | 30 | 59 | 4 | 32882513 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.42e-07 | 79 | 59 | 5 | 18757743 | |
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 2.58e-07 | 8 | 59 | 3 | 23055981 | |
| Pubmed | 2.58e-07 | 8 | 59 | 3 | 16546160 | ||
| Pubmed | 3.87e-07 | 9 | 59 | 3 | 12122015 | ||
| Pubmed | 3.87e-07 | 9 | 59 | 3 | 38844137 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.19e-07 | 560 | 59 | 9 | 21653829 | |
| Pubmed | 5.52e-07 | 10 | 59 | 3 | 33590845 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.76e-07 | 97 | 59 | 5 | 27559042 | |
| Pubmed | 1.01e-06 | 12 | 59 | 3 | 26794322 | ||
| Pubmed | 1.04e-06 | 196 | 59 | 6 | 19334288 | ||
| Pubmed | 1.31e-06 | 13 | 59 | 3 | 12682087 | ||
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 1.31e-06 | 13 | 59 | 3 | 20498044 | |
| Pubmed | 1.56e-06 | 210 | 59 | 6 | 16537572 | ||
| Pubmed | 1.62e-06 | 50 | 59 | 4 | 23658023 | ||
| Pubmed | 2.08e-06 | 15 | 59 | 3 | 33730615 | ||
| Pubmed | 2.08e-06 | 15 | 59 | 3 | 38537630 | ||
| Pubmed | Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signalling. | 2.56e-06 | 16 | 59 | 3 | 35132078 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12399449 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21851253 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17548619 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 2.83e-06 | 2 | 59 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 2.83e-06 | 2 | 59 | 2 | 21440062 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15131124 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25456503 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 2.83e-06 | 2 | 59 | 2 | 20404337 | |
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 2.83e-06 | 2 | 59 | 2 | 28669633 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 2.83e-06 | 2 | 59 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 2.83e-06 | 2 | 59 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 2.83e-06 | 2 | 59 | 2 | 7744963 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26408953 | ||
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 2.83e-06 | 2 | 59 | 2 | 19147489 | |
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 2.83e-06 | 2 | 59 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 2.83e-06 | 2 | 59 | 2 | 24833718 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24265020 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20529844 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23133647 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25014213 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21876163 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 2.83e-06 | 2 | 59 | 2 | 1852206 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12814948 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12429739 | ||
| Pubmed | Evidence for the phosphorylation of serine259 of histone deacetylase 5 by protein kinase Cδ. | 2.83e-06 | 2 | 59 | 2 | 21146494 | |
| Pubmed | Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis. | 2.83e-06 | 2 | 59 | 2 | 31343988 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21045140 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 2.83e-06 | 2 | 59 | 2 | 12524050 | |
| Pubmed | TGF-β1 promotes cell migration in hepatocellular carcinoma by suppressing reelin expression. | 2.83e-06 | 2 | 59 | 2 | 30447345 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8120105 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 2.83e-06 | 2 | 59 | 2 | 10504303 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15234972 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15221638 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 2.83e-06 | 2 | 59 | 2 | 25524144 | |
| Pubmed | Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration. | 2.83e-06 | 2 | 59 | 2 | 28662401 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29599141 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28238185 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 2.83e-06 | 2 | 59 | 2 | 16407178 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30997682 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10359653 | ||
| Pubmed | SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma. | 2.83e-06 | 2 | 59 | 2 | 33027505 | |
| Pubmed | 3.17e-06 | 59 | 59 | 4 | 21421844 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 3.72e-06 | 18 | 59 | 3 | 23041440 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 3.72e-06 | 18 | 59 | 3 | 39040056 | |
| Pubmed | 4.41e-06 | 19 | 59 | 3 | 20627076 | ||
| Pubmed | The transcription factor neurogenin 2 restricts cell migration from the cortex to the striatum. | 5.18e-06 | 20 | 59 | 3 | 11748150 | |
| Pubmed | Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules. | 5.95e-06 | 69 | 59 | 4 | 21491542 | |
| Pubmed | A high-resolution anatomical ontology of the developing murine genitourinary tract. | 6.03e-06 | 21 | 59 | 3 | 17452023 | |
| Pubmed | 6.03e-06 | 21 | 59 | 3 | 17943183 | ||
| Pubmed | 6.98e-06 | 22 | 59 | 3 | 25651362 | ||
| Pubmed | 6.98e-06 | 22 | 59 | 3 | 27527664 | ||
| Pubmed | Crk and Crkl Are Required in the Endocardial Lineage for Heart Valve Development. | 7.05e-06 | 72 | 59 | 4 | 37702066 | |
| Pubmed | 8.02e-06 | 23 | 59 | 3 | 14701881 | ||
| Pubmed | Lhx2 regulates the timing of β-catenin-dependent cortical neurogenesis. | 8.02e-06 | 23 | 59 | 3 | 26371318 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10825173 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10814726 | ||
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 8.48e-06 | 3 | 59 | 2 | 12270931 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 30201140 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 20971075 | ||
| Pubmed | A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. | 8.48e-06 | 3 | 59 | 2 | 1508194 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 7534784 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 20855508 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26472724 | ||
| Pubmed | Obstructed migration of Purkinje cells in the developing cerebellum of the reeler mutant mouse. | 8.48e-06 | 3 | 59 | 2 | 7506500 | |
| Pubmed | Proteoglycans are required for maintenance of Wnt-11 expression in the ureter tips. | 8.48e-06 | 3 | 59 | 2 | 8951078 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 31991528 | ||
| Pubmed | Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. | 8.48e-06 | 3 | 59 | 2 | 22066479 | |
| Interaction | ELN interactions | 1.21e-06 | 29 | 56 | 4 | int:ELN | |
| Interaction | MFAP2 interactions | 4.39e-06 | 12 | 56 | 3 | int:MFAP2 | |
| Interaction | HOXA1 interactions | 5.95e-06 | 356 | 56 | 8 | int:HOXA1 | |
| Interaction | PTPRK interactions | 9.51e-06 | 177 | 56 | 6 | int:PTPRK | |
| Interaction | ZFP41 interactions | 1.89e-05 | 57 | 56 | 4 | int:ZFP41 | |
| Interaction | ADAMTSL4 interactions | 3.01e-05 | 217 | 56 | 6 | int:ADAMTSL4 | |
| Interaction | FBN2 interactions | 3.19e-05 | 65 | 56 | 4 | int:FBN2 | |
| Interaction | NTN5 interactions | 3.95e-05 | 24 | 56 | 3 | int:NTN5 | |
| Interaction | IGFL3 interactions | 5.61e-05 | 75 | 56 | 4 | int:IGFL3 | |
| Interaction | EGFL7 interactions | 6.22e-05 | 77 | 56 | 4 | int:EGFL7 | |
| Interaction | SCUBE1 interactions | 7.54e-05 | 5 | 56 | 2 | int:SCUBE1 | |
| Interaction | DLL4 interactions | 1.13e-04 | 6 | 56 | 2 | int:DLL4 | |
| Interaction | LTBP1 interactions | 1.25e-04 | 92 | 56 | 4 | int:LTBP1 | |
| Interaction | DEFA1 interactions | 1.72e-04 | 100 | 56 | 4 | int:DEFA1 | |
| Interaction | CARD11 interactions | 1.87e-04 | 40 | 56 | 3 | int:CARD11 | |
| Cytoband | 6p21.1 | 1.54e-04 | 80 | 59 | 3 | 6p21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 4.76e-04 | 503 | 59 | 5 | chr6p21 | |
| Cytoband | 22q13 | 5.17e-04 | 26 | 59 | 2 | 22q13 | |
| Cytoband | 7p22.3 | 8.87e-04 | 34 | 59 | 2 | 7p22.3 | |
| Cytoband | 7q22 | 1.11e-03 | 38 | 59 | 2 | 7q22 | |
| Cytoband | 17q21 | 3.02e-03 | 63 | 59 | 2 | 17q21 | |
| GeneFamily | PHD finger proteins | 2.85e-06 | 90 | 45 | 5 | 88 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.04e-05 | 27 | 45 | 3 | 1253 | |
| GeneFamily | Fibulins | 1.68e-04 | 8 | 45 | 2 | 556 | |
| GeneFamily | C2 domain containing protein kinases | 2.69e-04 | 10 | 45 | 2 | 835 | |
| GeneFamily | Laminin subunits | 3.94e-04 | 12 | 45 | 2 | 626 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.01e-03 | 19 | 45 | 2 | 360 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.45e-03 | 40 | 45 | 2 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 7.35e-03 | 160 | 45 | 3 | 555 | |
| Coexpression | NABA_MATRISOME | NTN4 FBLN1 RELN SCUBE1 FBN1 FBN2 HMCN1 OTOGL TNC IL20 ITLN1 WNT7B SLIT1 SCUBE3 LAMB1 LAMB2 LTBP1 WNT4 ADAM12 SVEP1 MEGF10 BGN | 1.37e-16 | 1008 | 59 | 22 | MM17056 |
| Coexpression | NABA_MATRISOME | NTN4 FBLN1 RELN SCUBE1 FBN1 FBN2 HMCN1 TNC IL20 ITLN1 WNT7B SLIT1 SCUBE3 LAMB1 LAMB2 LTBP1 WNT4 ADAM12 FBN3 SVEP1 MEGF10 BGN | 1.98e-16 | 1026 | 59 | 22 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 OTOGL TNC SLIT1 LAMB1 LAMB2 LTBP1 SVEP1 | 3.26e-16 | 191 | 59 | 13 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 TNC SLIT1 LAMB1 LAMB2 LTBP1 FBN3 SVEP1 | 4.58e-16 | 196 | 59 | 13 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 OTOGL TNC SLIT1 LAMB1 LAMB2 LTBP1 SVEP1 BGN | 9.50e-16 | 270 | 59 | 14 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | NTN4 FBLN1 RELN FBN1 FBN2 HMCN1 TNC SLIT1 LAMB1 LAMB2 LTBP1 FBN3 SVEP1 BGN | 1.23e-15 | 275 | 59 | 14 | M5884 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.38e-08 | 385 | 59 | 10 | M39264 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.59e-08 | 200 | 59 | 8 | M5930 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | FBN1 HMCN1 BAZ1A TNC LAMB1 PLAUR LTBP1 SNAI1 ADAM12 KANK2 BGN | 3.03e-07 | 681 | 59 | 11 | M39175 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | FBN1 LRIG1 LAMB1 LAMB2 PRKCD PLAUR ADAM12 KANK2 CDH6 SVEP1 BGN | 1.38e-06 | 795 | 59 | 11 | M39050 |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 1.77e-06 | 257 | 59 | 7 | M13867 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.99e-06 | 40 | 59 | 4 | M5887 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 5.25e-06 | 196 | 59 | 6 | M2445 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 5.25e-06 | 303 | 59 | 7 | M39040 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 5.40e-06 | 197 | 59 | 6 | MM1320 | |
| Coexpression | GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN | 5.89e-06 | 200 | 59 | 6 | M7799 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 7.20e-06 | 17 | 59 | 3 | M47995 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 7.46e-06 | 767 | 59 | 10 | M39209 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 1.02e-05 | 19 | 59 | 3 | MM420 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.39e-05 | 352 | 59 | 7 | M17471 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.45e-05 | 137 | 59 | 5 | M40313 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.68e-05 | 505 | 59 | 8 | M39167 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.76e-05 | 365 | 59 | 7 | M39018 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.79e-05 | 69 | 59 | 4 | M10165 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_UP | 2.03e-05 | 147 | 59 | 5 | M2506 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 2.37e-05 | 74 | 59 | 4 | M13547 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | NTN4 RELN SCUBE1 HMCN1 DLL4 SCUBE3 LAMB1 PRKCQ SNAI1 WNT4 SVEP1 | 2.39e-05 | 1074 | 59 | 11 | M1941 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 3.05e-05 | 27 | 59 | 3 | M47994 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 3.09e-05 | 268 | 59 | 6 | M45796 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.34e-05 | 163 | 59 | 5 | M12112 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 3.84e-05 | 567 | 59 | 8 | M2129 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 4.19e-05 | 283 | 59 | 6 | M39117 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 4.56e-05 | 174 | 59 | 5 | M45676 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 5.08e-05 | 178 | 59 | 5 | M17079 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 5.76e-05 | 440 | 59 | 7 | M39039 | |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_UP | 6.42e-05 | 187 | 59 | 5 | M6738 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 6.74e-05 | 35 | 59 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.34e-05 | 36 | 59 | 3 | MM1212 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_MAC_UP | 8.82e-05 | 200 | 59 | 5 | M5162 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 8.82e-05 | 200 | 59 | 5 | M5261 | |
| Coexpression | TRAYNOR_RETT_SYNDROM_UP | 1.01e-04 | 40 | 59 | 3 | M2712 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.11e-04 | 338 | 59 | 6 | MM17064 | |
| Coexpression | NABA_SECRETED_FACTORS | 1.21e-04 | 343 | 59 | 6 | M5883 | |
| Coexpression | VANOEVELEN_MYOGENESIS_SIN3A_TARGETS | 1.41e-04 | 221 | 59 | 5 | M2524 | |
| Coexpression | VANOEVELEN_MYOGENESIS_SIN3A_TARGETS | 1.50e-04 | 224 | 59 | 5 | MM959 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 1.97e-04 | 50 | 59 | 3 | M1259 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 2.19e-04 | 131 | 59 | 4 | M40316 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.21e-04 | 52 | 59 | 3 | MM1118 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.37e-04 | 738 | 59 | 8 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 2.67e-04 | 751 | 59 | 8 | M5885 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 2.70e-04 | 11 | 59 | 2 | M566 | |
| Coexpression | MEL18_DN.V1_UP | 2.90e-04 | 141 | 59 | 4 | M2784 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS | 2.98e-04 | 142 | 59 | 4 | M40152 | |
| Coexpression | DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS | 3.14e-04 | 144 | 59 | 4 | M40230 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 3.24e-04 | 12 | 59 | 2 | M47983 | |
| Coexpression | CSR_LATE_UP.V1_DN | 3.40e-04 | 147 | 59 | 4 | M2659 | |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | 3.68e-04 | 272 | 59 | 5 | MM3634 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS | 3.68e-04 | 595 | 59 | 7 | M40167 | |
| Coexpression | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP | 3.82e-04 | 13 | 59 | 2 | M17359 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 4.09e-04 | 64 | 59 | 3 | M2572 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 4.15e-04 | 1242 | 59 | 10 | M1920 | |
| Coexpression | JONES_OVARY_STROMAL | 4.26e-04 | 156 | 59 | 4 | M48352 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 4.89e-04 | 68 | 59 | 3 | M1406 | |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_UP | 5.08e-04 | 292 | 59 | 5 | M5369 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_PARTIAL | 5.14e-04 | 164 | 59 | 4 | M2502 | |
| Coexpression | GSE37301_PRO_BCELL_VS_CD4_TCELL_DN | 5.26e-04 | 165 | 59 | 4 | M8907 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 5.32e-04 | 295 | 59 | 5 | M39121 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 5.40e-04 | 296 | 59 | 5 | M41675 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 5.55e-04 | 71 | 59 | 3 | M2948 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 5.79e-04 | 72 | 59 | 3 | M45791 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.86e-04 | 16 | 59 | 2 | MM1296 | |
| Coexpression | LEE_LIVER_CANCER_HEPATOBLAST | 5.86e-04 | 16 | 59 | 2 | M13123 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.86e-04 | 16 | 59 | 2 | M2207 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS | 5.95e-04 | 645 | 59 | 7 | M40158 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 6.29e-04 | 173 | 59 | 4 | M2385 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 6.52e-04 | 75 | 59 | 3 | MM1143 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 6.53e-04 | 1316 | 59 | 10 | MM1052 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 7.14e-04 | 179 | 59 | 4 | M39308 | |
| Coexpression | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN | 7.29e-04 | 180 | 59 | 4 | M10605 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 7.45e-04 | 18 | 59 | 2 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 7.45e-04 | 18 | 59 | 2 | M13796 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 7.45e-04 | 18 | 59 | 2 | M47984 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 8.17e-04 | 1115 | 59 | 9 | M10371 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 8.31e-04 | 19 | 59 | 2 | M15125 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 8.33e-04 | 493 | 59 | 6 | M19391 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_UP | 8.41e-04 | 187 | 59 | 4 | M4861 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 8.57e-04 | 188 | 59 | 4 | MM1071 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 9.07e-04 | 84 | 59 | 3 | M15484 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN | 9.22e-04 | 20 | 59 | 2 | M8321 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 9.22e-04 | 20 | 59 | 2 | MM17053 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 9.39e-04 | 85 | 59 | 3 | M45761 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 9.64e-04 | 194 | 59 | 4 | M39122 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 9.67e-04 | 337 | 59 | 5 | M13206 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 9.67e-04 | 337 | 59 | 5 | MM16606 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 1.00e-03 | 196 | 59 | 4 | M4514 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 1.04e-03 | 88 | 59 | 3 | M5360 | |
| Coexpression | GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN | 1.06e-03 | 199 | 59 | 4 | M3384 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN | 1.06e-03 | 199 | 59 | 4 | M9599 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 1.06e-03 | 199 | 59 | 4 | M7341 | |
| Coexpression | GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.08e-03 | 200 | 59 | 4 | M9685 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.98e-08 | 337 | 57 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 1.37e-07 | 148 | 57 | 7 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.24e-07 | 437 | 57 | 10 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.33e-07 | 439 | 57 | 10 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 2.93e-07 | 450 | 57 | 10 | GSM777063_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 2.99e-07 | 166 | 57 | 7 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.04e-07 | 466 | 57 | 10 | GSM777050_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.60e-07 | 261 | 57 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 5.78e-07 | 370 | 57 | 9 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 7.19e-07 | 189 | 57 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 8.51e-07 | 65 | 57 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 8.69e-07 | 284 | 57 | 8 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 9.08e-07 | 122 | 57 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.32e-06 | 207 | 57 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | RELN SCUBE1 HMCN1 TNC SLIT1 CNTNAP2 SCUBE3 WNT4 ADAM12 FBN3 SVEP1 MEGF10 BGN | 1.49e-06 | 981 | 57 | 13 | Arv_EB-LF_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.59e-06 | 146 | 57 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 2.65e-06 | 445 | 57 | 9 | GSM777043_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 3.38e-06 | 734 | 57 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 4.54e-06 | 91 | 57 | 5 | GSM777059_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 5.52e-06 | 487 | 57 | 9 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FBLN1 SCUBE1 FBN1 FBN2 HMCN1 TNC LAMB1 ADAM12 CDH6 SVEP1 BGN | 5.82e-06 | 777 | 57 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.22e-06 | 97 | 57 | 5 | GSM777043_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.76e-06 | 265 | 57 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | RELN SCUBE1 DLL4 SLIT1 CNTNAP2 SCUBE3 WNT4 ADAM12 LIN28A FBN3 SVEP1 MEGF10 | 1.02e-05 | 992 | 57 | 12 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.05e-05 | 827 | 57 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.10e-05 | 831 | 57 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.50e-05 | 418 | 57 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.87e-05 | 310 | 57 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.91e-05 | 311 | 57 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | SCUBE1 FBN1 FBN2 TNC AMZ1 WNT7B SCUBE3 LAMB1 LAMB2 MLLT6 PLAUR LTBP1 CDH6 FBN3 | 2.42e-05 | 1466 | 57 | 14 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 2.44e-05 | 740 | 57 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.63e-05 | 327 | 57 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 2.70e-05 | 749 | 57 | 10 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.75e-05 | 455 | 57 | 8 | GSM777055_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 3.34e-05 | 768 | 57 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | SCUBE1 FBN1 HMCN1 SLIT1 SCUBE3 PLAUR ADAM12 CDH6 FBN3 SVEP1 BGN | 3.82e-05 | 951 | 57 | 11 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | 3.94e-05 | 783 | 57 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 | |
| CoexpressionAtlas | placenta | 3.98e-05 | 349 | 57 | 7 | placenta | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.36e-05 | 354 | 57 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 4.52e-05 | 356 | 57 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 4.60e-05 | 357 | 57 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 4.93e-05 | 361 | 57 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 5.07e-05 | 496 | 57 | 8 | PCBC_EB_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | NTN4 RELN FBN2 TNC CNTNAP2 LAMB1 MLLT6 PLAUR LTBP1 CD163 BRWD1 | 5.11e-05 | 982 | 57 | 11 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 5.12e-05 | 27 | 57 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 5.14e-05 | 497 | 57 | 8 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_100 | 5.18e-05 | 76 | 57 | 4 | gudmap_developingKidney_e12.5_renal vesicle_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | RELN SCUBE1 DLL4 SLIT1 CNTNAP2 SCUBE3 WNT4 ADAM12 FBN3 SVEP1 MEGF10 | 5.70e-05 | 994 | 57 | 11 | PCBC_EB_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 5.86e-05 | 371 | 57 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 7.76e-05 | 388 | 57 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.92e-05 | 267 | 57 | 6 | gudmap_developingKidney_e12.5_renal vesicle_1000_k3 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 8.05e-05 | 165 | 57 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.77e-05 | 168 | 57 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.03e-04 | 280 | 57 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.23e-04 | 418 | 57 | 7 | PCBC_ratio_MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.29e-04 | 96 | 57 | 4 | GSM777063_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.33e-04 | 423 | 57 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | NTN4 SCUBE1 FBN1 FBN2 HMCN1 SLIT1 SCUBE3 ADAM12 CDH6 SVEP1 BGN | 1.34e-04 | 1094 | 57 | 11 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 1.49e-04 | 431 | 57 | 7 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.53e-04 | 433 | 57 | 7 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.60e-04 | 191 | 57 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000 | 1.79e-04 | 761 | 57 | 9 | gudmap_developingKidney_e15.5_Endothelial cells_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.99e-04 | 316 | 57 | 6 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 2.01e-04 | 773 | 57 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.13e-04 | 320 | 57 | 6 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#3_top-relative-expression-ranked_100 | 2.25e-04 | 44 | 57 | 3 | gudmap_developingKidney_e12.5_renal vesicle_100_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 2.41e-04 | 975 | 57 | 10 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | RELN SCUBE1 WNT7B SLIT1 CNTNAP2 SCUBE3 WNT4 CDH6 LIN28A FBN3 | 2.43e-04 | 976 | 57 | 10 | PCBC_ECTO_blastocyst_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 2.43e-04 | 793 | 57 | 9 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | RELN SCUBE1 SLIT1 CNTNAP2 SCUBE3 WNT4 ADAM12 FBN3 SVEP1 MEGF10 | 2.63e-04 | 986 | 57 | 10 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 2.72e-04 | 990 | 57 | 10 | JC_fibro_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.76e-04 | 336 | 57 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 2.85e-04 | 118 | 57 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | 3.14e-04 | 121 | 57 | 4 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | 3.18e-04 | 345 | 57 | 6 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 3.50e-04 | 496 | 57 | 7 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 3.55e-04 | 497 | 57 | 7 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 3.59e-04 | 498 | 57 | 7 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | 4.23e-04 | 855 | 57 | 9 | gudmap_developingKidney_e13.5_podocyte cells_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.75e-04 | 135 | 57 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#3_top-relative-expression-ranked_500 | 4.84e-04 | 57 | 57 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k3 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | NTN4 HDAC5 WDR75 LRIG1 BAZ1A TNC PLAUR PRKCQ KANK2 LIN28A FBN3 | 5.05e-04 | 1276 | 57 | 11 | PCBC_ratio_MESO-5_vs_MESO-15_cfr-2X-p05 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 5.91e-04 | 143 | 57 | 4 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 6.55e-04 | 147 | 57 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 6.72e-04 | 148 | 57 | 4 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 6.76e-04 | 398 | 57 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 7.99e-04 | 411 | 57 | 6 | GSM538239_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.10e-04 | 936 | 57 | 9 | JC_hmvEC_2500_K1 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.18e-04 | 156 | 57 | 4 | ratio_MESO_vs_SC_1000_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 8.18e-04 | 156 | 57 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 8.30e-04 | 414 | 57 | 6 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 8.98e-04 | 1153 | 57 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | NTN4 RELN SCUBE1 BAZ1A DGKK SLIT1 CNTNAP2 XKR6 MLLT10 CDH6 BRWD1 | 9.13e-04 | 1370 | 57 | 11 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_200 | 9.20e-04 | 161 | 57 | 4 | gudmap_developingKidney_e12.5_renal vesicle_200 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K1 | 9.21e-04 | 71 | 57 | 3 | facebase_RNAseq_e9.5_MaxArch_2500_K1 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 9.35e-04 | 281 | 57 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 9.35e-04 | 281 | 57 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 9.98e-04 | 73 | 57 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 1.04e-03 | 74 | 57 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 1.09e-03 | 291 | 57 | 5 | gudmap_kidney_P2_CapMes_Crym_500 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-13 | 200 | 59 | 10 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.12e-12 | 197 | 59 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-12 | 198 | 59 | 9 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.86e-12 | 200 | 59 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-12 | 200 | 59 | 9 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-12 | 200 | 59 | 9 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.86e-12 | 200 | 59 | 9 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.09e-10 | 181 | 59 | 8 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-10 | 192 | 59 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-10 | 192 | 59 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-10 | 192 | 59 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.06e-10 | 196 | 59 | 8 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.15e-10 | 197 | 59 | 8 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-10 | 197 | 59 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.15e-10 | 197 | 59 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.32e-10 | 199 | 59 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.32e-10 | 199 | 59 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-10 | 199 | 59 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-10 | 199 | 59 | 8 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.42e-10 | 200 | 59 | 8 | e663995fc44c340d878d66b278b7b5c2ff784301 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-10 | 200 | 59 | 8 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.42e-10 | 200 | 59 | 8 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-10 | 200 | 59 | 8 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.42e-10 | 200 | 59 | 8 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.42e-10 | 200 | 59 | 8 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.42e-10 | 200 | 59 | 8 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.42e-10 | 200 | 59 | 8 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-10 | 200 | 59 | 8 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-09 | 176 | 59 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-09 | 176 | 59 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.87e-09 | 178 | 59 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-09 | 181 | 59 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.05e-09 | 185 | 59 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.05e-09 | 185 | 59 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.05e-09 | 185 | 59 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-09 | 185 | 59 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-09 | 185 | 59 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-09 | 186 | 59 | 7 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.65e-09 | 188 | 59 | 7 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-09 | 189 | 59 | 7 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-09 | 189 | 59 | 7 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-09 | 190 | 59 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.30e-09 | 191 | 59 | 7 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-09 | 191 | 59 | 7 | ba02cbdfda6a94374a6472eb88499059979af472 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.30e-09 | 191 | 59 | 7 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-09 | 193 | 59 | 7 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.77e-09 | 193 | 59 | 7 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.77e-09 | 193 | 59 | 7 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.77e-09 | 193 | 59 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-09 | 194 | 59 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.02e-09 | 194 | 59 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-09 | 194 | 59 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.02e-09 | 194 | 59 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-09 | 194 | 59 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 7.02e-09 | 194 | 59 | 7 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.02e-09 | 194 | 59 | 7 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 195 | 59 | 7 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-09 | 195 | 59 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-09 | 195 | 59 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-09 | 195 | 59 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 195 | 59 | 7 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-09 | 195 | 59 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-09 | 195 | 59 | 7 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-09 | 196 | 59 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 7.53e-09 | 196 | 59 | 7 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-09 | 196 | 59 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-09 | 196 | 59 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-09 | 196 | 59 | 7 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-09 | 196 | 59 | 7 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-09 | 196 | 59 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-09 | 197 | 59 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.80e-09 | 197 | 59 | 7 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.80e-09 | 197 | 59 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.80e-09 | 197 | 59 | 7 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.08e-09 | 198 | 59 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-09 | 198 | 59 | 7 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.08e-09 | 198 | 59 | 7 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-09 | 198 | 59 | 7 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.08e-09 | 198 | 59 | 7 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.08e-09 | 198 | 59 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 8.08e-09 | 198 | 59 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.08e-09 | 198 | 59 | 7 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.37e-09 | 199 | 59 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.37e-09 | 199 | 59 | 7 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.37e-09 | 199 | 59 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 8.37e-09 | 199 | 59 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.37e-09 | 199 | 59 | 7 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.37e-09 | 199 | 59 | 7 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.37e-09 | 199 | 59 | 7 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.66e-09 | 200 | 59 | 7 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.66e-09 | 200 | 59 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.66e-09 | 200 | 59 | 7 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.66e-09 | 200 | 59 | 7 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-09 | 200 | 59 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.66e-09 | 200 | 59 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-09 | 200 | 59 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.66e-09 | 200 | 59 | 7 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 8.66e-09 | 200 | 59 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.66e-09 | 200 | 59 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.66e-09 | 200 | 59 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| Computational | Adhesion molecules. | 8.67e-11 | 141 | 41 | 10 | MODULE_122 | |
| Computational | ECM and collagens. | 1.71e-06 | 225 | 41 | 8 | MODULE_47 | |
| Computational | Metal / Ca ion binding. | 1.41e-04 | 133 | 41 | 5 | MODULE_324 | |
| Computational | Neighborhood of EGFR | 2.37e-04 | 32 | 41 | 3 | GNF2_EGFR | |
| Computational | Neighborhood of TIMP2 | 6.98e-04 | 46 | 41 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 8.40e-04 | 49 | 41 | 3 | GNF2_KISS1 | |
| Drug | pyrachlostrobin | GPR146 NTN4 SCUBE1 FBN1 BAZ1A TNC LAMB2 PRKCD PLAUR LTBP1 KANK2 SVEP1 MEGF10 | 9.68e-08 | 811 | 58 | 13 | ctd:C513428 |
| Drug | Rgd Peptide | 1.60e-07 | 239 | 58 | 8 | CID000104802 | |
| Drug | belinostat | 7.37e-06 | 678 | 58 | 10 | ctd:C487081 | |
| Drug | desmosine | 1.01e-05 | 53 | 58 | 4 | CID000025435 | |
| Drug | Af1 Neuropeptide | 1.04e-05 | 17 | 58 | 3 | CID000164289 | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 2295_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.08e-05 | 197 | 58 | 6 | 3549_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.11e-05 | 198 | 58 | 6 | 4351_UP | |
| Drug | Sikvav | 3.06e-05 | 24 | 58 | 3 | CID005487517 | |
| Drug | AC1L2A3V | 4.47e-05 | 77 | 58 | 4 | CID000068615 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 4.70e-05 | 155 | 58 | 5 | 6817_DN | |
| Drug | AC1L1B58 | 5.47e-05 | 29 | 58 | 3 | CID000001288 | |
| Drug | hyaluronan | 5.49e-05 | 263 | 58 | 6 | CID000024759 | |
| Drug | prochloraz | 6.09e-05 | 268 | 58 | 6 | ctd:C045362 | |
| Drug | lead stearate | 6.28e-05 | 84 | 58 | 4 | CID000061258 | |
| Drug | 2-(2,6-diisopropylphenyl)-5-hydroxy-1H-isoindole-1,3-dione | 6.35e-05 | 5 | 58 | 2 | ctd:C501339 | |
| Drug | NSC49080 | 8.11e-05 | 33 | 58 | 3 | CID000002192 | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.53e-05 | 180 | 58 | 5 | 1477_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.17e-04 | 188 | 58 | 5 | 5493_UP | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.23e-04 | 190 | 58 | 5 | 6213_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.23e-04 | 190 | 58 | 5 | 3253_DN | |
| Drug | Calcort | 1.24e-04 | 38 | 58 | 3 | CID000026709 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.26e-04 | 191 | 58 | 5 | 6498_UP | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 193 | 58 | 5 | 5985_DN | |
| Drug | calcein blue | 1.33e-04 | 7 | 58 | 2 | CID005393133 | |
| Drug | FR 139317 | 1.33e-04 | 7 | 58 | 2 | ctd:C079574 | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 3526_UP | |
| Drug | (+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A | 1.36e-04 | 194 | 58 | 5 | 606_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 2687_UP | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 6104_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 3478_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 4156_DN | |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 2795_UP | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 2501_UP | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 3453_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 1487_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 5061_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 4151_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 3327_DN | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 4012_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 2858_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 3801_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 2119_UP | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 2786_UP | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 1.46e-04 | 197 | 58 | 5 | 1042_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 6811_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 5664_UP | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 4737_UP | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HG-U133A | 1.46e-04 | 197 | 58 | 5 | 484_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 5746_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 1501_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 5737_DN | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 5984_UP | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 3839_DN | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 4836_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.49e-04 | 198 | 58 | 5 | 2346_DN | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 6523_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 5570_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A | 1.53e-04 | 199 | 58 | 5 | 365_DN | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 5756_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 5412_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; PC3; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 4543_DN | |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 6307_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; HL60; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 2543_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.53e-04 | 199 | 58 | 5 | 3845_DN | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 3030_UP | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 7308_DN | |
| Drug | norethisterone oenanthate | 1.73e-04 | 109 | 58 | 4 | CID000019688 | |
| Drug | B-Ms | 2.05e-04 | 114 | 58 | 4 | CID000445091 | |
| Drug | abamectin | 2.27e-04 | 9 | 58 | 2 | ctd:C048324 | |
| Drug | funiferine N-oxide | 2.66e-04 | 49 | 58 | 3 | CID000191631 | |
| Drug | thiamylal | 2.66e-04 | 49 | 58 | 3 | CID003032285 | |
| Drug | polymarcine | 2.83e-04 | 10 | 58 | 2 | ctd:C008971 | |
| Drug | auranofin | 3.17e-04 | 52 | 58 | 3 | CID006918453 | |
| Drug | 2,3-pentanedione | 3.29e-04 | 129 | 58 | 4 | ctd:C013186 | |
| Drug | AC1L1G72 | 3.46e-04 | 11 | 58 | 2 | CID000003553 | |
| Drug | BM165 | 3.46e-04 | 11 | 58 | 2 | CID003352881 | |
| Drug | 1xqc | 3.46e-04 | 11 | 58 | 2 | CID005287617 | |
| Drug | G 3012 | 3.59e-04 | 132 | 58 | 4 | CID000120739 | |
| Drug | kalinin | 3.75e-04 | 55 | 58 | 3 | CID000032518 | |
| Disease | connective tissue disease (implicated_via_orthology) | 7.59e-09 | 3 | 59 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | NTN4 RELN SCUBE1 FBN1 FBN2 LRIG1 AMZ1 CUL9 LINC01548 WNT4 XKR6 ADAM12 LIN28A FBN3 SVEP1 | 4.24e-08 | 1345 | 59 | 15 | EFO_0010736 |
| Disease | birth weight, pelvic organ prolapse | 2.86e-06 | 49 | 59 | 4 | EFO_0004344, EFO_0004710 | |
| Disease | serum IgG glycosylation measurement | 9.26e-06 | 523 | 59 | 8 | EFO_0005193 | |
| Disease | scoliosis (is_implicated_in) | 2.35e-05 | 4 | 59 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | hemangioblastoma (is_marker_for) | 2.35e-05 | 4 | 59 | 2 | DOID:5241 (is_marker_for) | |
| Disease | Malformation of cortical development | 5.87e-05 | 6 | 59 | 2 | cv:C1955869 | |
| Disease | Lissencephaly | 5.87e-05 | 6 | 59 | 2 | cv:C0266463 | |
| Disease | cortical thickness | RELN SCUBE1 FBN1 FBN2 BAZ1A CUL9 LINC01548 XKR6 MLLT10 ADAM12 | 6.55e-05 | 1113 | 59 | 10 | EFO_0004840 |
| Disease | autistic disorder (is_implicated_in) | 8.25e-05 | 42 | 59 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | hemangiopericytoma (is_marker_for) | 1.40e-04 | 9 | 59 | 2 | DOID:264 (is_marker_for) | |
| Disease | FEV/FEC ratio | 1.47e-04 | 1228 | 59 | 10 | EFO_0004713 | |
| Disease | aortic measurement | 1.47e-04 | 251 | 59 | 5 | EFO_0020865 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.66e-04 | 53 | 59 | 3 | C4707243 | |
| Disease | body mass index, osteoarthritis | 1.75e-04 | 54 | 59 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | ascending aortic diameter | 1.80e-04 | 140 | 59 | 4 | EFO_0021787 | |
| Disease | Prostatic Neoplasms | 2.22e-04 | 616 | 59 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.22e-04 | 616 | 59 | 7 | C0376358 | |
| Disease | pulmonary hypertension (is_marker_for) | 2.90e-04 | 64 | 59 | 3 | DOID:6432 (is_marker_for) | |
| Disease | FVC change measurement, response to placebo | 3.02e-04 | 13 | 59 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | Endometrioma | 3.08e-04 | 161 | 59 | 4 | C0269102 | |
| Disease | Endometriosis | 3.08e-04 | 161 | 59 | 4 | C0014175 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 4.06e-04 | 15 | 59 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | uterine prolapse | 4.63e-04 | 16 | 59 | 2 | EFO_1001864 | |
| Disease | intraocular pressure measurement | 5.32e-04 | 509 | 59 | 6 | EFO_0004695 | |
| Disease | ulcerative colitis | 5.55e-04 | 335 | 59 | 5 | EFO_0000729 | |
| Disease | behavior or behavioral disorder measurement, personality trait | 5.89e-04 | 18 | 59 | 2 | EFO_0004365, EFO_0004782 | |
| Disease | liver cirrhosis (is_marker_for) | 6.01e-04 | 82 | 59 | 3 | DOID:5082 (is_marker_for) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 6.58e-04 | 19 | 59 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | QT interval | 6.83e-04 | 534 | 59 | 6 | EFO_0004682 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 7.30e-04 | 20 | 59 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | carpal tunnel syndrome | 7.63e-04 | 89 | 59 | 3 | EFO_0004143 | |
| Disease | osteoarthritis | 1.03e-03 | 222 | 59 | 4 | MONDO_0005178 | |
| Disease | systemic scleroderma (is_implicated_in) | 1.05e-03 | 24 | 59 | 2 | DOID:418 (is_implicated_in) | |
| Disease | Endogenous Hyperinsulinism | 1.24e-03 | 26 | 59 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 1.24e-03 | 26 | 59 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 1.24e-03 | 26 | 59 | 2 | C1257965 | |
| Disease | Malignant neoplasm of breast | 1.28e-03 | 1074 | 59 | 8 | C0006142 | |
| Disease | colorectal cancer | 1.29e-03 | 604 | 59 | 6 | MONDO_0005575 | |
| Disease | transforming growth factor beta measurement | 1.34e-03 | 27 | 59 | 2 | EFO_0004818 | |
| Disease | Major Depressive Disorder | 1.43e-03 | 243 | 59 | 4 | C1269683 | |
| Disease | pneumonia (is_marker_for) | 1.44e-03 | 28 | 59 | 2 | DOID:552 (is_marker_for) | |
| Disease | Hyperinsulinism | 1.44e-03 | 28 | 59 | 2 | C0020459 | |
| Disease | Hyperglycemia, Postprandial | 1.65e-03 | 30 | 59 | 2 | C1855520 | |
| Disease | osteoarthritis, hip, body mass index | 1.65e-03 | 30 | 59 | 2 | EFO_0004340, EFO_1000786 | |
| Disease | Hyperglycemia | 1.65e-03 | 30 | 59 | 2 | C0020456 | |
| Disease | Unipolar Depression | 1.81e-03 | 259 | 59 | 4 | C0041696 | |
| Disease | Schizophrenia | 1.85e-03 | 883 | 59 | 7 | C0036341 | |
| Disease | Autistic Disorder | 1.86e-03 | 261 | 59 | 4 | C0004352 | |
| Disease | joint hypermobility measurement | 1.99e-03 | 33 | 59 | 2 | EFO_0007905 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTHKSACVGRMGHCC | 136 | A8MWP4 | |
| ACMTCNRHGCRQAFH | 136 | P55198 | |
| GMVQCCKVTCHELCH | 251 | Q400G9 | |
| HGGTCHDLENGLMCT | 451 | Q9NR61 | |
| GVHECAMQCHGRGVC | 656 | O43184 | |
| GSCVNMVGSFHCRCP | 261 | Q75N90 | |
| ECRMLAHLCAHGECI | 2366 | Q75N90 | |
| ENMVLCDGCDRGHHT | 1161 | Q9NRL2 | |
| CHHVTGECSCPSGWM | 246 | Q96KG7 | |
| AVHSMSPCHRSCFCG | 51 | A6NM66 | |
| MPVSSQCAVCHESCG | 406 | Q5KSL6 | |
| CAGMRVTGCNTEHHC | 251 | Q8WWA0 | |
| KCDACGMNVHHRCQT | 261 | Q04759 | |
| HKMEHGGRVVCSDCN | 921 | Q96JA1 | |
| CEDCGMNVHHKCREK | 261 | Q05655 | |
| VICHLPCMNGGQCSS | 401 | Q14766 | |
| AMCPFGCHCHLRVVQ | 61 | P21810 | |
| ADCGHPCMAPCHTSS | 861 | Q12986 | |
| GHCMCRHNTKGLNCE | 296 | P07942 | |
| HAEGMVHGACICKHN | 301 | P55268 | |
| MCSGHGSCDHGICRC | 1036 | P78509 | |
| CAAGNPCSHSCHNAM | 5111 | Q96RW7 | |
| CCADGHRMATHQKDC | 36 | P23142 | |
| CENTKGSFICHCDMG | 1296 | P35555 | |
| ECSNGTHMCSQHADC | 1366 | P35555 | |
| CDPIAMSQCSSDHGC | 1851 | Q9NSI6 | |
| CTCHGGEPEMCVAAL | 296 | P98153 | |
| TSSHCQRVCPCPHGM | 206 | P14616 | |
| CPHGMACTARGECCH | 216 | P14616 | |
| DGSTALMCACEHGHK | 771 | Q63ZY3 | |
| SCVGFVCQPMCSHAA | 76 | A8MX34 | |
| NEGCLHMTCAKCNHG | 2246 | Q8IWT3 | |
| VRVCACDHHGNMQSC | 586 | P55285 | |
| MCAIIDRCVPNHCEH | 551 | Q9UHC6 | |
| KDLRLCHAHMTCHCG | 121 | Q9NYY1 | |
| HCERCVRMPGCQHGT | 56 | Q6UY11 | |
| CMCGNTHVHPEHAGR | 696 | Q9UQL6 | |
| CEIGAHNCDMHASCL | 1371 | P35556 | |
| CGDRHCSPDHMGVQQ | 316 | Q96CH1 | |
| HCTGTEQHMGDCPVT | 651 | Q86VB7 | |
| CMNKDHGCAHICRET | 166 | Q8IWY4 | |
| CMNKNHGCAHICRET | 161 | Q8IX30 | |
| CAVVCQKGMLYHHCS | 741 | Q3ZCN5 | |
| GKCMCKHNTAGSHCQ | 291 | Q9HB63 | |
| MGSCKCGTHTGHFEC | 291 | Q4LDE5 | |
| CSEEMTACHSGPCLN | 726 | Q99466 | |
| TGACMTCNKHGCRQA | 151 | P55197 | |
| ARGGCMHFHCTQCRH | 881 | Q96EP0 | |
| MQLECKCHGVSGSCT | 196 | P56706 | |
| MHIRSHTLPCVCGTC | 171 | O95863 | |
| SEPGESSSMHICHCC | 46 | Q5GH73 | |
| RGCATASMCQHAHLG | 261 | Q03405 | |
| MAWGGVHTCCFHLCC | 1 | Q6UXN2 | |
| CHPTEDCIASGHMDG | 211 | Q8IWA0 | |
| CQTCAGNMTECPGHF | 71 | P24928 | |
| SDMSCPNDCHQHGRC | 466 | P24821 | |
| PNDCHQHGRCVNGMC | 471 | P24821 | |
| LNGGCHEHATCKMTG | 2131 | Q8WWQ8 | |
| NHLCTACMNNGVCHE | 221 | Q02763 | |
| ACMNNGVCHEDTGEC | 226 | Q02763 | |
| CMSLCAECFHQGDHT | 141 | Q6ZT12 | |
| HMRVECKCHGVSGSC | 201 | P56705 | |
| MCHCEAGWVGLHCDQ | 1361 | O75093 | |
| SCMQCGAASPGFHCE | 1476 | O14686 | |
| CHFCQSISHMVASCP | 161 | Q9H9Z2 |